ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ)
$4.21 -0.04 (-0.9412%)
Analysed ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) News Sources
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
12-08-2025
yahoo.com
Companies Like OnKure Therapeutics (NASDAQ:OKUR) Could Be Quite Risky
19-08-2025
yahoo.com
3 Promising Penny Stocks With Market Caps Under $200M
31-10-2025
yahoo.com
OnKure Therapeutics to Participate in Upcoming Investor Conferences
04-11-2025
yahoo.com
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
06-11-2025
yahoo.com
Promising Penny Stocks To Watch In December 2025
09-12-2025
yahoo.com
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
12-03-2026
yahoo.com
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
27-03-2026
yahoo.com
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?
16-04-2026
yahoo.com
OnKure Therapeutics Reports First Quarter 2026 Financial Results
05-05-2026
yahoo.com
What is the current price of ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ)?
The current price of ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) is $4.21.
ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) since the previous trading day is $-0.04.
ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) since the previous trading day is -0.9412%.
What is the most recent average sentiment score for ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ)?
The most recent average sentiment score for ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ)?
The most recent sentiment for ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ) is .
SEC-8K** Filing Available For ONKURE THERAPEUTICS INC-A (OKUR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.